{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:16:53Z","timestamp":1761488213063},"reference-count":66,"publisher":"Wiley","issue":"s1","license":[{"start":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T00:00:00Z","timestamp":1236211200000},"content-version":"vor","delay-in-days":6822,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vox Sanguinis"],"published-print":{"date-parts":[[1990,7]]},"abstract":"<jats:p><jats:bold>Abstract. <\/jats:bold> The influence of high\u2010dose intravenous immunoglobulins (HD\u2010IVIG) on the clinical status and T4 cell count of adults with AIDS\u2010related complex (ARC) and Walter\u2010Reed 5 (WR5) was evaluated in a randomized double\u2010blind longitudinal study. Inclusion criteria were: (1) T4 cells &lt;400\/\u03bcl and (2a) oral thrush or cutaneous anergy or (2b) two clinical ARC criteria (fever, diarrhea, weight loss, fatigue, night sweats). Thirty patients [28 males, 2 females, median age 41 (24\u201364) years] with ARC (n = 8), WR5 (n = 12) and both (n = 10) were stratified according to their T4 cell count (\u2265 vs. &lt;300\/\u03bcl). Fifteen patients received 0.4g\/kg body weight IVIG and 15 placebo (albumin 0.03%) every other week for 26 weeks with follow\u2010up for another 26 weeks. The clinical status was defined as a score consisting of fever, diarrhea, night sweats, fatigue, weight loss, oral candidiasis and mucosal or cutaneous herpes simplex. Clinical examination and routine laboratory assessments were performed before initiation of the study and before each administration, lymphocyte phenotyping every 4 weeks and cutaneous reaction, serology and lymphocyte stimulation every 12 weeks. Both groups were comparable in initial clinical symptoms and laboratory values. Seven patients developed AIDS (treatment group: 3, placebo group: 4), 1 patient died by homicide. After 26 weeks, the clinical score (particularly fatigue and fever) was significantly improved in the treatment group, while the T4 cell count and other clinical and immunological parameters remained unaltered. This limited effect was still evident at termination of the study after 52 weeks. In conclusion, HD\u2010IVIG can improve the clinical status of patients with advanced HIV\u20101 infection without obviously correcting the underlying impaired cellular immunity. The substitution of intact antibodies in the state of functional hypogammaglobulinemia is suggested as possible therapeutic mechanism.<\/jats:p>","DOI":"10.1111\/j.1423-0410.1990.tb01637.x","type":"journal-article","created":{"date-parts":[[2009,3,6]],"date-time":"2009-03-06T02:07:57Z","timestamp":1236305277000},"page":"3-14","source":"Crossref","is-referenced-by-count":15,"title":["High\u2010Dose Intravenous Immunoglobulins in HIV\u20101\u2010Infected Adults with AIDS\u2010Related Complex and Walter\u2010Reed 5"],"prefix":"10.1111","volume":"59","author":[{"given":"M.","family":"Schrappe\u2010B\u00e4cher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Rasokat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ch.","family":"Bendick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.W.","family":"Bube","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St.","family":"Degenhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"F\u00e4tkenheuer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.J.","family":"Heiniger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Heitmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Imbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Krickeberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Mauff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Meller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Th.","family":"Mertens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Morell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.A.","family":"Perret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Plum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ramon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Salzberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.B.","family":"Schaad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Siebel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.J.","family":"Sp\u00e4th","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"St\u00fctzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"T\u00fcrk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. R. F.","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,3,5]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0260-4639(22)00099-8","article-title":"AIDS\u2010related conditions","volume":"6","author":"Abrams DI","year":"1986","journal-title":"Clin Immunol Allergy"},{"key":"e_1_2_1_3_2","first-page":"334","article-title":"Classification system for human T\u2010lymphotropic virus type III\/lymphadenopathy\u2010associated virus infections","volume":"35","author":"Centers for Disease Control","year":"1986","journal-title":"MMWR"},{"key":"e_1_2_1_4_2","first-page":"234","volume-title":"AIDS \u2013 A Basic Guide for Clinicians","author":"Ebbessen P.","year":"1984"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)92624-2"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198611203152112"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198507113130204"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.83.23.9124"},{"key":"e_1_2_1_9_2","first-page":"83","article-title":"Hypergammaglobulinemia associated with human immunodeficiency virus infection","volume":"23","author":"Reimer CB","year":"1988","journal-title":"Monogr Allergy"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112595"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198308253090803"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00915157"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)91244-5"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(85)80505-9"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-198605010-00014"},{"key":"e_1_2_1_16_2","first-page":"143","article-title":"Restoration of suppressor T cell functions in children with AIDS following intravenous gammaglobulin treatment","volume":"140","author":"Gupta A.","year":"1986","journal-title":"Am J Dis Child"},{"key":"e_1_2_1_17_2","unstructured":"EstreichS. GohBT ForsterGE et al.Bacterial infections on patients with human immunodeficiency virus infection (abstract No. 7087); inIV Int Conf on AIDS Stockholm June 1988."},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-198805000-00006"},{"key":"e_1_2_1_19_2","unstructured":"RolstonK. RadentzS. RodriguezS. et al.Bacterial infections in AIDS patients (abstract No. 7083); inIV Int Conf on AIDS Stockholm June 1988."},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-198800001-00027"},{"key":"e_1_2_1_21_2","first-page":"652","article-title":"Infectious cofactors in HIV (HTLV\u2010III\/LAV)\u2010positive individuals and their implication for cause and prognosis of acquired immune deficiency","volume":"1","author":"Krueger GRF","year":"1986","journal-title":"AIDS-Forschung"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-0934(88)90059-6"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1987.03390190095027"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/154.4.556"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/154.5.864"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198810063191403"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-101-4-435"},{"key":"e_1_2_1_28_2","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1182\/blood.V73.2.366.366","article-title":"Crossover study of immunoglobulin replacement therapy in patients with low\u2010grade B cell tumors","volume":"73","author":"Griffiths H.","year":"1989","journal-title":"Blood"},{"key":"e_1_2_1_29_2","first-page":"140","article-title":"Clinical use of intravenous immunoglobulins","volume":"25","author":"Berkman SA","year":"1988","journal-title":"Semin Hematol"},{"key":"e_1_2_1_30_2","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1182\/blood.V62.2.398.398","article-title":"Reversal of neutropenia with intravenous gammaglobulin in autoimmune neutropenia of infancy","volume":"62","author":"Bussel J.","year":"1983","journal-title":"Blood"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1986.tb02006.x"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(87)90551-1"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)90400-3"},{"key":"e_1_2_1_34_2","first-page":"39","article-title":"The use of human intravenous immune globulins in immunoregulatory disorders and in the newborn period","volume":"8","author":"Stiehm ER","year":"1988","journal-title":"Immunol Allergy Clin North Am"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V62.2.480.480"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00320269"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.132.6.1279"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110104"},{"key":"e_1_2_1_39_2","first-page":"200","article-title":"Modulation of the immune response by immunoglobulin for intravenous use. Use of pokeweed mitogen\u2010induced B cell differentiation","volume":"62","author":"Stohl W.","year":"1985","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)90701-3"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01727524"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1982.tb00014.x"},{"key":"e_1_2_1_43_2","unstructured":"HagueRA WilliamsPE MokJ. et al.Treatment of children born to HIV antibody\u2010positive mothers with intravenous immunoglobulin (IV IgG) (abstract No. 7248); inIV Int Conf on AIDS Stockholm June 1988."},{"key":"e_1_2_1_44_2","unstructured":"KreuzW. EbenerU. WegerichB. et al.Clinical and immunological course of HIV infection in hemophiliac and perinatally infected children prophylactically treated with immunoglobulines containing high titers of anti\u2010CMV anti\u2010EBV and anti\u2010HIV and timing of azidothymidine indication. A prospective longitudinal study of 61 children (abstract); inV Int Conf on AIDS Montr\u00e9al June 1989 p.329."},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(85)90275-X"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00442700"},{"key":"e_1_2_1_47_2","unstructured":"Ayg\u00f6renE. Hach\u2010WunderleV. St\u00f6rkelF. et al.Response to immunoglobulin therapy (IVIG) in 10 hemophiliacs with antibodies to HIV\u20101 (abstract); inXVIII Int Congr of the World Federation of Hemophilia Madrid May 1988."},{"key":"e_1_2_1_48_2","unstructured":"Br\u00fcckmannC. AubergerK. GandenbergerS. et al.Continuous i.v. immunoglobulin substitution (IVIG) in HIV\u2010positive haemophilic patients (abstract); inin XVIII Int Congr of the World Federation of Hemophilia Madrid May 1988."},{"key":"e_1_2_1_49_2","unstructured":"BrunkhorstU. BesseS. WillersH. et al.Gammaglobulin treatment of symptomatic HIV\u20101 infection (abstract No. 7251); inIV Int Conf on AIDS Stockholm June 1988."},{"key":"e_1_2_1_50_2","first-page":"1S","article-title":"Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome","volume":"36","author":"Centers for Disease Control","year":"1987","journal-title":"MMWR"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1990.tb01640.x"},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1990.tb01639.x"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1990.tb01641.x"},{"key":"e_1_2_1_54_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1990.tb01638.x"},{"key":"e_1_2_1_55_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1990.tb01642.x"},{"key":"e_1_2_1_56_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1990.tb01643.x"},{"key":"e_1_2_1_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(81)90058-8"},{"key":"e_1_2_1_58_2","first-page":"199","volume-title":"Evaluation of Chemotherapeutic Agents","author":"Karnofsky DA","year":"1949"},{"key":"e_1_2_1_59_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1990.tb01644.x"},{"key":"e_1_2_1_60_2","unstructured":"OffiziGP MezzaromaI. PesceAM et al.Intravenous immunoglobulins (IVIG) in HIV\u20101\u2010infected patients: A randomized study (abstract No. 7250); inIV Int Conf on AIDS Stockholm June 1988."},{"key":"e_1_2_1_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)91738-5"},{"key":"e_1_2_1_62_2","first-page":"177","article-title":"Intravenous immune serum globulin replacement in hypogammaglobulinemia","volume":"23","author":"Gelfand EW","year":"1988","journal-title":"Monogr Allergy"},{"key":"e_1_2_1_63_2","first-page":"62","article-title":"Serum IgG subclass levels in primary and acquired immunodeficiency","volume":"20","author":"Aucouturier P.","year":"1986","journal-title":"Monogr Allergy"},{"key":"e_1_2_1_64_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/153.5.970"},{"key":"e_1_2_1_65_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2418502"},{"key":"e_1_2_1_66_2","doi-asserted-by":"crossref","unstructured":"DammaccoF. IodiceG. CampobassoN.Treatment of adult patients with idiopathic thrombocytopenic purpura with intravenous immunoglobulins: Effects on circulating T cell subsets and PWM\u2010induced antibody synthesis in vitro.Br J Haematol1986:125\u2013135.","DOI":"10.1111\/j.1365-2141.1986.tb02908.x"},{"key":"e_1_2_1_67_2","first-page":"697","article-title":"Alteration of T cell subsets in vitro during high\u2010dose gammaglobulin therapy in patients with idiopathic thrombocytopenic purpura","volume":"53","author":"Tsubakio T.","year":"1983","journal-title":"Clin Exp Immunol"}],"container-title":["Vox Sanguinis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1423-0410.1990.tb01637.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1423-0410.1990.tb01637.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T22:08:00Z","timestamp":1695766080000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1423-0410.1990.tb01637.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,7]]},"references-count":66,"journal-issue":{"issue":"s1","published-print":{"date-parts":[[1990,7]]}},"alternative-id":["10.1111\/j.1423-0410.1990.tb01637.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1423-0410.1990.tb01637.x","archive":["Portico"],"relation":{},"ISSN":["0042-9007","1423-0410"],"issn-type":[{"value":"0042-9007","type":"print"},{"value":"1423-0410","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,7]]}}}